Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal.

Int J Chron Obstruct Pulmon Dis · 2018 · PMC6296179 · PMID 30587953

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

As discussed above, the only two large properly designed RCTs showed a decrease in risk of death that was borderline significant, 23 or not statistically significant. 25 Both studies compared a combination of ICS/LABA with placebo and with each of the components.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.